Adverse events1,495

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,495

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Global Pembrolizumab + Standard of Care First Course	157	350	269
other	Anaemia	Blood and lymphatic system disorders	Global Standard of Care	159	346	257
other	Anaemia	Blood and lymphatic system disorders	Japan Pembrolizumab + Trastuzumab + S-1 Plus Oxaliplatin	5	20	6
other	Anaemia	Blood and lymphatic system disorders	Japan Trastuzumab + S-1 Plus Oxaliplatin	4	20	4
other	Anaemia	Blood and lymphatic system disorders	Global Pembrolizumab + Standard of Care Second Course	2	11	4
other	Leukopenia	Blood and lymphatic system disorders	Global Pembrolizumab + Standard of Care First Course	12	350	26
other	Leukopenia	Blood and lymphatic system disorders	Global Standard of Care	23	346	46
other	Leukopenia	Blood and lymphatic system disorders	Japan Pembrolizumab + Trastuzumab + S-1 Plus Oxaliplatin	0	20	0
other	Leukopenia	Blood and lymphatic system disorders	Japan Trastuzumab + S-1 Plus Oxaliplatin	0	20	0
other	Leukopenia	Blood and lymphatic system disorders	Global Pembrolizumab + Standard of Care Second Course	0	11	0
other	Neutropenia	Blood and lymphatic system disorders	Global Pembrolizumab + Standard of Care First Course	59	350	133
other	Neutropenia	Blood and lymphatic system disorders	Global Standard of Care	57	346	111
other	Neutropenia	Blood and lymphatic system disorders	Japan Pembrolizumab + Trastuzumab + S-1 Plus Oxaliplatin	1	20	2
other	Neutropenia	Blood and lymphatic system disorders	Japan Trastuzumab + S-1 Plus Oxaliplatin	0	20	0
other	Neutropenia	Blood and lymphatic system disorders	Global Pembrolizumab + Standard of Care Second Course	0	11	0
other	Thrombocytopenia	Blood and lymphatic system disorders	Global Pembrolizumab + Standard of Care First Course	43	350	67
other	Thrombocytopenia	Blood and lymphatic system disorders	Global Standard of Care	43	346	71
other	Thrombocytopenia	Blood and lymphatic system disorders	Japan Pembrolizumab + Trastuzumab + S-1 Plus Oxaliplatin	0	20	0
other	Thrombocytopenia	Blood and lymphatic system disorders	Japan Trastuzumab + S-1 Plus Oxaliplatin	0	20	0
other	Thrombocytopenia	Blood and lymphatic system disorders	Global Pembrolizumab + Standard of Care Second Course	0	11	0

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03615326/events

API reference For AI assistants

Adverse events1,495

Sources 3

Read this list from software.